Hargabka KaiBiLi&Covid-19 Antigen Duo Tijaabada Degdega ah
Hordhac
Calaamadaha bukaan-socodka iyo calaamadaha caabuqa fayraska neef-mareenka ee uu keeno SARS-CoV-2 iyo hargabku waxay la mid noqon karaan.SARS-CoV-2, hargabka A iyo hargabka B fayras antigens ayaa guud ahaan laga ogaan karaa shaybaarada neef-mareenka sare inta lagu jiro marxaladda ba'an ee caabuqa.
Fayraska hargabku waxa iska leh qoyska Orthomyxoviridae, iyo difaac ahaan kala duwan, fayraska RNA-ganacsan.Halkaa waxaa jira fayraska hargabka A iyo B waa cudur-sidaha ugu weyn ee cudurrada daran ku dhaca dadka iyo noocyada xoolaha.Iyada oo ku saleysan baaritaanka cudurrada faafa ee hadda, muddada soo-baxa waa 1 ilaa 4 maalmood.Calaamadaha ugu waaweyn waxaa ka mid ah qandho ba'an, xanuun guud iyo calaamadaha neefsashada.Nooca A iyo fayrasyada B labaduba waxay wareegi karaan isku mar, laakiin inta badan hal nooc ayaa ku badan inta lagu jiro xilli go'an.1
COVID-19 waa cudur faafa oo neef-mareenka oo degdeg ah.Dadku guud ahaan waa u nugul yihiin.Hadda, bukaannada uu ku dhacay cudurka 'coronavirus' cusub ayaa ah isha ugu weyn ee caabuqa;Dadka cudurka asymptomatic-ka ah sidoo kale waxay noqon karaan il faafa.Iyada oo ku saleysan baaritaanka cudurrada faafa ee hadda, muddada soo-baxa waa 1 ilaa 14 maalmood, badiyaa 3 ilaa 7 maalmood.Calaamadaha ugu waaweyn waxaa ka mid ah qandho, daal iyo qufac qalalan.Sanka oo ciriiri ah, diif, cune xanuun, myalgia iyo shuban ayaa laga helaa dhowr xaaladood.
KaiBiLiTMFlu & COVID-19 Antigen Duo Tijaabada Degdegga ah waxaa loogu talagalay in isla mar la ogaado tayada tayada iyo kala soocida antigens-ka borotiinka nucleocapsid ee SARS-CoV-2, hargabka A iyo hargabka B ee muunadaha nasopharyngeal tooska ah (NP).Ogaanshaha waxa uu ku salaysan yahay unugyada difaaca jirka kuwaas oo la sameeyay iyaga oo si gaar ah u aqoonsanaya ugana falcelinaya nukleoprotein-ka fayraska.
Ogaanshaha
KaiBiLiTMHargabka & COVID-19 Antigen Duo Tijaabada Degdega ah waa ogaanshaha tayada ee isku mar ah iyo kala soocida antigens-ka borotiinka nucleocapsid ee SARS-CoV-2, hargabka A iyo hargabka B ee muunadaha nasopharyngeal tooska ah (NP).
Tusaalooyinka
Nasopharyngeal
Xadka ogaanshaha (LoD)
SARS-CoV-2 & Hargab: 140 TCID50/ml
Hargabka A
| Cadaadiska Fayraska Hargabka | LOD la xisaabiyay (TCID50/ml) |
| A/New Caledonia/20/1999_H1N1 | 8.50x103 |
| A/California/04/2009_H1N1 | 2.11x103 |
| A/PR/8/34_H1N1 | 2.93x103 |
| A/Bean Goose/Hubei/chenhu XVI35-1/2016_H3N2 | 4.94x102 |
| A/Guizhou/54/89_H3N2 | 3.95x102 |
| A/ Aadanaha/Hubei/3/2005_H3N2 | 2.93x104 |
| Goose-madaxeed leh ee Bar/QH/BTY2/2015_H5N1 | 1.98x105 |
| A/Anhui/1/2013_H7N9 | 7.90x105 |
Hargabka B.
| Cadaadiska Fayraska Hargabka | La xisaabiyayLOD(TCID50/ml) |
| B/Victoria | 4.25x103 |
| B/Yamagata | 1.58x102 |
Saxnaanta
| Hargabka A | Hargabka B | COVID-19 | |
| Dareenka Qaraabada | 86.80% | 91.70% | 96.60% |
| Gaar ahaan Qaraabada | 94% | 97.50% | 100% |
| Saxnaanta | 92.20% | 96.10% | 98.90% |
Waqtiga Natiijooyinka
Natiijooyinka ku akhri 15daqiiqo oo aan ka badnayn 30 daqiiqo.
Xaaladaha kaydinta qalabka
2 ~ 30°C.
Nuxurka
| Qalabka tijaabi | 20 imtixaan |
| suufyo jeermis dilay | 20 pcs. |
| Tuubooyinka soo saarista (oo leh 0.5ml soo saarista) | 20 pcs. |
| Ku dabool shaandhada | 20 pcs. |
| Tube Stand | 1 pcs. |
| Gelida Xidhmada | 1 pcs. |
Dalbashada Macluumaadka
| Alaabta | Bisad.Maya. | Nuxurka |
| KaiBiLiTMHargabka & COVID-19 Antigen Duo | P211137 | 20 imtixaan |
